Patents by Inventor Douglas K. Price

Douglas K. Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SLCO1B3 genotype
    Patent number: 10094836
    Abstract: The invention relates methods of identifying and predicting inter-patient differences in prognostic prediction for survival in androgen independent prostate cancer. It further related to methods for determining and exploiting such differences to improve medical outcomes. Moreover, it provides methods for determining if a subject has prostate cancer.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: October 9, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: William D. Figg, Alex Sparreboom, Akinobu Hamada, Douglas K. Price, Tristan M. Sissung
  • SLCO1B3 GENOTYPE
    Publication number: 20100317726
    Abstract: The invention relates methods of identifying and predicting inter-patient differences in prognostic prediction for survival in androgen independent prostate cancer. It further related to methods for determining and exploiting such differences to improve medical outcomes. Moreover, it provides methods for determining if a subject has prostate cancer.
    Type: Application
    Filed: January 8, 2008
    Publication date: December 16, 2010
    Applicant: Government of the United States of America, as rep resented by the Secretary Dept. of Health and Hum
    Inventors: William D. Figg, Alex Sparreboom, Akinobu Hamada, Douglas K. Price, Tristan M. Sissung
  • Cyp1B1 Genotype
    Publication number: 20100280084
    Abstract: The invention relates to pharmacology, pharmacokinetics and toxicology, and more specifically to methods of identifying and predicting inter-patient differences in response to drugs in order to achieve superior efficacy and safety in selected patient populations. It further related to the genetic basis of inter-patient variation in response to therapy, including drug therapy, and to methods for determining and exploiting such differences to improve medical outcomes.
    Type: Application
    Filed: September 8, 2006
    Publication date: November 4, 2010
    Applicant: Government of the US, as represented by the Secret ary, Department of Health and Human Services
    Inventors: William D. Figg, Alex Sparreboom, Tristan M. Sissung, Douglas K. Price
  • Method for detecting prostate cells
    Patent number: 5858673
    Abstract: There is provided a sensitive multiplex RT-PCR assay for the detection of circulating prostate antigen expressing cells. Multiplex PCR uses multiple sets of primers to concurrently amplify different DNA sequences that can be readily resolved by gel electrophoresis. When applied to blood samples from prostate cancer patients, the nested multiplex RT-PCR can simultaneously detect PSA-expressing cells, PSM-expressing cells, and a ubiquitously expressed internal PCR control gene, glyceraldehyde 3-phosphate dehydrogenase (G3PDH), all within a single reaction.
    Type: Grant
    Filed: May 5, 1997
    Date of Patent: January 12, 1999
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventors: Douglas K. Price, Chris M. Teigland